Literature DB >> 30456594

The role of osteopontin in kidney diseases.

Beata Kaleta1.   

Abstract

BACKGROUND: Osteopontin (OPN) is a pleiotropic glycoprotein expressed in various cell types in animals and in humans, including bone, immune, smooth muscle, epithelial and endothelial cells. Moreover, OPN is found in kidneys (in the thick ascending limbs of the loop of Henle and in distal nephrons) and urine. The protein plays an important role in mineralization and bone resorption. In addition, OPN is involved in the regulation of immunity and inflammation, angiogenesis and apoptosis. It was demonstrated that OPN and some OPN gene polymorphic variants are associated with the pathogenesis and progression of multiple disorders, such as cancer, autoimmune, neurodegenerative and cardiovascular diseases. Moreover, recent studies suggested that OPN is associated with the pathogenesis of renal failure.
METHODS: In this review, I briefly discussed the role of OPN and its gene polymorphisms in kidney physiology, as well as in various kidney diseases. FINDINGS AND
CONCLUSION: Most studies reported that OPN expression is elevated in urolithiasis, and also in acute and chronic kidney diseases, and in renal allograft dysfunction. Moreover, it was demonstrated that polymorphic variants of the OPN gene may be associated with renal failure. However, some reports suggested that OPN is essential for tubulogenesis, and that it inhibits calcium oxalate crystal formation and retention, nitric oxide synthesis, cell apoptosis and promotes cell regeneration. Thus, further studies are required to fully understand the role of OPN in kidney physiology and pathology. Eventually, these studies may result in the identification of OPN as a valuable marker for renal dysfunction prognosis and treatment.

Entities:  

Keywords:  Kidney; Kidney disease; Marker; Osteopontin

Mesh:

Substances:

Year:  2018        PMID: 30456594     DOI: 10.1007/s00011-018-1200-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  115 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.

Authors:  X Gang; K Ueki; S Kon; M Maeda; T Naruse; Y Nojima
Journal:  Am J Kidney Dis       Date:  2001-02       Impact factor: 8.860

3.  Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.

Authors:  S A Mezzano; M A Droguett; M E Burgos; L G Ardiles; C A Aros; I Caorsi; J Egido
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

Review 4.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

5.  Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion.

Authors:  V P Persy; W A Verstrepen; D K Ysebaert; K E De Greef; M E De Broe
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

6.  Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys.

Authors:  I Hara; H Miyake; K Yamanaka; S Hara; S Arakawa; S Kamidono
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

7.  Osteopontin expression in fetal and mature human kidney.

Authors:  K L Hudkins; C M Giachelli; Y Cui; W G Couser; R J Johnson; C E Alpers
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

8.  Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.

Authors:  X Q Yu; L L Wu; X R Huang; N Yang; R E Gilbert; M E Cooper; R J Johnson; K N Lai; H Y Lan
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

9.  Interaction between osteopontin on madin darby canine kidney cell membrane and calcium oxalate crystal.

Authors:  T Yamate; K Kohri; T Umekawa; E Konya; Y Ishikawa; M Iguchi; T Kurita
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

10.  Quantification of osteopontin in the urine of healthy and stone-forming men.

Authors:  T Yasui; K Fujita; Y Hayashi; K Ueda; S Kon; M Maeda; T Uede; K Kohri
Journal:  Urol Res       Date:  1999-08
View more
  25 in total

1.  Kidney Diseases: The Age of Molecular Markers.

Authors:  Glaucia Luciano da Veiga; Beatriz da Costa Aguiar Alves; Matheus Moreira Perez; Joyce Regina Raimundo; Jéssica Freitas de Araújo Encinas; Neif Murad; Fernando Luiz Affonso Fonseca
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Prediction of cellular targets in diabetic kidney diseases with single-cell transcriptomic analysis of db/db mouse kidneys.

Authors:  Chenhua Wu; Yingjun Tao; Nan Li; Jingjin Fei; Yurong Wang; Jie Wu; Harvest F Gu
Journal:  J Cell Commun Signal       Date:  2022-07-09       Impact factor: 5.782

3.  Single-Nucleus Transcriptional Profiling of Chronic Kidney Disease after Cisplatin Nephrotoxicity.

Authors:  Zhengwei Ma; Xiaoru Hu; Han-Fei Ding; Ming Zhang; Yuqing Huo; Zheng Dong
Journal:  Am J Pathol       Date:  2022-01-31       Impact factor: 4.307

4.  Hydroxycitrate prevents calcium oxalate crystallization and kidney injury in a nephrolithiasis rat model.

Authors:  Bowei Yang; Jiongming Li; Bin Wang; Guang Wang; Pei Li; Haixiang Guo; Yuhang Li; Tongxin Yang
Journal:  Urolithiasis       Date:  2021-08-19       Impact factor: 3.436

5.  Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD.

Authors:  John D Imig
Journal:  Kidney360       Date:  2022-09-29

6.  Single-Cell Profiling of AKI in a Murine Model Reveals Novel Transcriptional Signatures, Profibrotic Phenotype, and Epithelial-to-Stromal Crosstalk.

Authors:  Valeria Rudman-Melnick; Mike Adam; Andrew Potter; Saagar M Chokshi; Qing Ma; Keri A Drake; Meredith P Schuh; J Matthew Kofron; Prasad Devarajan; S Steven Potter
Journal:  J Am Soc Nephrol       Date:  2020-10-28       Impact factor: 10.121

Review 7.  Osteopontin and Transplantation: Where Are We Now?

Authors:  Beata Kaleta
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-05-21       Impact factor: 4.291

Review 8.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

9.  Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study.

Authors:  Yurong Cheng; Yong Li; Nora Scherer; Franziska Grundner-Culemann; Terho Lehtimäki; Binisha H Mishra; Olli T Raitakari; Matthias Nauck; Kai-Uwe Eckardt; Peggy Sekula; Ulla T Schultheiss
Journal:  PLoS Genet       Date:  2022-04-06       Impact factor: 5.917

10.  High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia.

Authors:  Gaowa Bai; Daisuke Furushima; Toshiro Niki; Takashi Matsuba; Yosuke Maeda; Atsushi Takahashi; Toshio Hattori; Yugo Ashino
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.